Norepinephrine Bitartrate 8 mg Added to 0 — Class II drug recall D-1070-2017
Terminated recall by Cantrell Drug Company, reported 2017-08-16, distributed nationwide. Lack of Sterility Assurance.
| Recall number | D-1070-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cantrell Drug Company, Little Rock, AR, United States |
| Recall initiated | 2017-07-14 |
| Classified | 2017-08-09 |
| Reported by FDA | 2017-08-16 |
| Terminated | 2020-09-16 |
| Distributed | Nationwide (US) |
| Quantity | 8,928 bags |
| Reason classes | sterility |
| NDC | 52533-0217-18 |
| Lot numbers | 10095, 10119, 10135, 10162, 10168, 10186, 10247, 10301, 10325, 10390, 10465, 10487, 10542 |
| Expiration dates | 2017-07-27, 2017-07-31, 2017-08-02, 2017-08-06, 2017-08-07, 2017-08-09, 2017-08-15, 2017-08-21, 2017-08-24, 2017-09-05, 2017-09-18, 2017-09-20, 2017-09-27 |
Product
Norepinephrine Bitartrate 8 mg Added to 0.9% Sodium Chloride 250 mL (32 mcg per mL) Single-Dose Bag, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-217-18
Reason for recall
Lack of Sterility Assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1070-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.